Early blood profiles of virus infection in a monkey model for Lassa fever.
about
Advanced vaccine candidates for Lassa feverTranscriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposureStructure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppressionA Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies.Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection.Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infectionsProteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha.Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics.Comparative pathogenesis and systems biology for biodefense virus vaccine development.Reactive astrogliosis in response to hemorrhagic fever virus: microarray profile of Junin virus-infected human astrocytes.Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses.Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection.Pathogenesis of arenavirus hemorrhagic fevers.A systems biology starter kit for arenaviruses.Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidateDelayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaquesGenomic profiling of host responses to Lassa virus: therapeutic potential from primate to manPathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitroAlcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infectionSafety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.Analysis of the differential host cell nuclear proteome induced by attenuated and virulent hemorrhagic arenavirus infectionMacaque models of human infectious disease.A systems biology view of cancerFibroblastic reticular cells and their role in viral hemorrhagic fevers.Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever.Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.Host cell factors as antiviral targets in arenavirus infection.Arenavirus evasion of host anti-viral responses.Meta-analysis of high-throughput datasets reveals cellular responses following hemorrhagic fever virus infection.Vaccine platforms to control Lassa fever.Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.Gene expression in primate liver during viral hemorrhagic fever.A Primate Model for Viral Hemorrhagic Fever.Diagnostics for Lassa Fever: Detecting Host Antibody Responses.
P2860
Q26823627-59A60168-3C42-4554-80B8-B164539D566EQ27305228-F23D5A5F-C76C-42C4-9372-D8D168FEFEEFQ27666703-1C284AF9-3549-48F1-8EC7-610CBF64A4E2Q30250910-87D8AB0F-BAD6-45F3-8659-0827100552F0Q33524893-370FD54A-63EC-41D7-AB3B-3655238F3107Q33549960-9CB9E29D-18F0-4438-8DA0-E106AA2BAE85Q33656417-6712FF0B-1AF1-4C2E-96F9-64EB20CE5F5EQ33905046-EF835BD8-372F-43B3-BAA3-91BDA1F40499Q33959989-BB6CB879-A78C-44B1-9290-2ECEE3E65DEAQ33963386-499B95B3-EEDC-483C-94CC-4B1D1E0A65ACQ34266468-B484A7A3-4117-4406-9C72-6CAFA3D3E6C8Q34515519-D52C1012-140F-42EE-82E4-7EA9C044D3D8Q34625899-75BD7FB9-37B2-4617-8450-D23502267B5DQ34647510-C2E56B3B-3D75-4F37-80F1-713C55BD50B4Q34999818-1E835685-A074-4DA0-9D61-DF758B73ECB5Q35076680-A62BE580-C66C-4DA7-A5AC-9E4B67F4C632Q35248863-EA440994-0791-4A41-934F-C5F7B1D7BD34Q36155495-38F12D4E-1852-43FF-BF56-B2FC2E1FCBAAQ36387183-38578B48-7636-4787-840D-13253677E55AQ36698306-9BF6763A-B597-4B83-893F-A73D7EF34996Q36806151-322C4E89-6BA6-49A8-B828-2324CD1E102BQ36970552-B32163D4-A8CF-4AC7-98F0-5172D0F32549Q37033404-AFEC0479-7414-4632-8547-5E26BFF7FE69Q37103536-562B9653-4C5A-4E5E-BEEB-DFFA42E878B9Q37434945-A1F65B72-E60F-4FD7-B700-3B9D76A53351Q37463214-A458A3F9-FB69-4544-8B31-AEA89624FE20Q37464889-7655BB83-666E-44B0-BD71-41709378EF16Q37884343-49955556-06BF-4B0C-8CFB-488863B03C28Q37912497-3EE408B2-7069-432E-993F-474284E12924Q38061425-FBCBD38C-0961-4434-B889-26E03CF227FBQ38064279-7ABAC1C2-E011-4AF6-9D6C-BD5941C30EB9Q38615950-9A297BF9-6096-42B1-9A2D-5D606173C127Q38823264-9DEDDA46-540C-4A6D-9F6A-9BF44CD1DB40Q40285838-34701D41-AF65-423C-9EA3-9C07B9027981Q40397175-AAAB64F1-746D-4B09-BB39-131065C36C36Q41922365-1BC0230D-2F8E-4CCC-A377-0E100073B459Q41922464-0E77F351-BB4E-4558-8197-74BA41CB99B6
P2860
Early blood profiles of virus infection in a monkey model for Lassa fever.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Early blood profiles of virus infection in a monkey model for Lassa fever.
@en
type
label
Early blood profiles of virus infection in a monkey model for Lassa fever.
@en
prefLabel
Early blood profiles of virus infection in a monkey model for Lassa fever.
@en
P2093
P2860
P356
P1433
P1476
Early blood profiles of virus infection in a monkey model for Lassa fever
@en
P2093
Bruno Sobral
C David Pauza
Harry Davis
Igor S Lukashevich
Joseph Bryant
Mahmoud M Djavani
Maria S Salvato
Mark Swindells
Marti Jett
Oswald R Crasta
P2860
P304
P356
10.1128/JVI.00536-07
P407
P577
2007-05-23T00:00:00Z